Loading clinical trials...
Loading clinical trials...
Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Chu Dijon Bourgogne
Dijon, France
Start Date
March 1, 2020
Primary Completion Date
May 31, 2022
Completion Date
May 31, 2022
Last Updated
September 22, 2022
273
ACTUAL participants
Biological data
BIOLOGICAL
Clinical data
OTHER
Lead Sponsor
Centre Hospitalier Universitaire Dijon
NCT05198791
NCT06744322
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07301034